BioCentury
ARTICLE | Clinical News

MACI regulatory update

January 25, 2016 8:00 AM UTC

Vericel submitted a BLA to FDA for MACI to treat symptomatic knee cartilage defects in adults. Vericel (formerly Aastrom Biosciences Inc.) acquired the matrix-induced autologous chondrocyte implant f...